MaxCyte (MXCT) has released an update.
MaxCyte, Inc., a leader in cell engineering technology, is set to announce its third quarter financial results for 2024 on November 6th, after the U.S. market close. A conference call led by company management will follow at 4:30 p.m. Eastern Time to discuss the outcomes. Interested investors can register online to listen in and can also access a live webcast via the MaxCyte website.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
